ATE316979T1 - Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt - Google Patents

Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt

Info

Publication number
ATE316979T1
ATE316979T1 AT97928617T AT97928617T ATE316979T1 AT E316979 T1 ATE316979 T1 AT E316979T1 AT 97928617 T AT97928617 T AT 97928617T AT 97928617 T AT97928617 T AT 97928617T AT E316979 T1 ATE316979 T1 AT E316979T1
Authority
AT
Austria
Prior art keywords
protein
coagulase
binding protein
staphylococus
negative
Prior art date
Application number
AT97928617T
Other languages
English (en)
Inventor
Bengt Guss
Martin Nilsson
Lars Frykberg
Jan-Ingmar Flock
Martin Lindberg
Original Assignee
Biostapro Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biostapro Ab filed Critical Biostapro Ab
Application granted granted Critical
Publication of ATE316979T1 publication Critical patent/ATE316979T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97928617T 1996-06-20 1997-06-18 Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt ATE316979T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602496A SE9602496D0 (sv) 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology

Publications (1)

Publication Number Publication Date
ATE316979T1 true ATE316979T1 (de) 2006-02-15

Family

ID=20403140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97928617T ATE316979T1 (de) 1996-06-20 1997-06-18 Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt

Country Status (10)

Country Link
US (2) US6733758B1 (de)
EP (1) EP0922056B1 (de)
JP (1) JP4173549B2 (de)
AT (1) ATE316979T1 (de)
AU (1) AU3282597A (de)
CA (1) CA2294433A1 (de)
DE (1) DE69735207T2 (de)
ES (1) ES2258280T3 (de)
SE (1) SE9602496D0 (de)
WO (1) WO1997048727A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
EP1034277B1 (de) * 1997-11-26 2012-06-27 Inhibitex, Inc. Extrazelluläre Matrix-bindende Proteine von Staphylococcus aureus
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
WO2000012132A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
BR9913311A (pt) * 1998-08-31 2001-10-16 Trinity College Dublin Molécula de ácido nucleico isolado, ácido nucleico isolado, vetor, proteìna, anticorpo e anti-soros formados contra uma proteìna, kit de diagnóstico, processos para reduzir a infecção de estafilococos coagulase-negativos de um dispositivo médico de retenção, para tratar uma infecção de estafilococus coagulase-negativa, para prevenir uma infecção de estafilococos coagulase-negativa em um paciente, para induzir uma resposta imunológica e para identificar compostos que inibem estafilococos coagulase-negativos
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
AU771426B2 (en) * 1998-08-31 2004-03-18 Inhibitex, Inc. Multicomponent vaccines
US20040038327A1 (en) * 1999-08-31 2004-02-26 Foster Timothy J. Antibodies to polypeptides from coagulase-negative staphylococci
WO2002102829A2 (en) 2001-06-15 2002-12-27 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
CA2478029A1 (en) * 2002-03-05 2003-09-18 Inhibitex, Inc. Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
WO2004080490A2 (en) 2003-03-07 2004-09-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
EP2298340B1 (de) 2004-09-22 2014-04-16 GlaxoSmithKline Biologicals S.A. Immunogene Zusammensetzung zur Verwendung zur Impfung gegen Staphylokokken
MY148405A (en) 2006-03-30 2013-04-30 Glaxosmithkline Biolog Sa Immunogenic composition
US20080234626A1 (en) * 2006-04-26 2008-09-25 Chelak Todd M Multi-stage microporation device
CN102481352A (zh) 2009-06-22 2012-05-30 惠氏有限责任公司 金黄色葡萄球菌抗原的免疫原性组合物
TR201809128T4 (tr) 2009-07-15 2018-07-23 Aimm Therapeutics Bv Gram-pozitif bakterilere spesifik bağlanan bileşikler.
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
EP4171736A4 (de) 2020-06-27 2024-07-03 Crescenta Biosciences Neuartige verbindungen zur modulation des zellmetabolismus und verwendungen davon
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583987D1 (de) 1984-11-06 1991-10-10 Thomae Gmbh Dr K Antibiotisches polypeptid, verfahren zu seiner herstellung und seine verwendung.
ATE95187T1 (de) * 1988-07-15 1993-10-15 Thomae Gmbh Dr K Verfahren zur gewinnung, isolierung und reinigung von epidermin.
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
DE69331758T2 (de) * 1992-09-21 2002-11-14 Alfa-Laval Agri International Ab, Tumba Fibrinogen-bildungsprotein
IL109410A0 (en) * 1993-04-30 1994-07-31 Ell Lilly & Company Fema gene of staphylococcus epidermidis, fema protein, and vectors and microorganisms comprising the fema gene
US6107068A (en) * 1995-12-22 2000-08-22 The University Of British Columbia Coenzyme A disulfide reductase, and inhibitors thereof useful as antimicrobial agents

Also Published As

Publication number Publication date
CA2294433A1 (en) 1997-12-24
EP0922056A1 (de) 1999-06-16
EP0922056B1 (de) 2006-02-01
AU3282597A (en) 1998-01-07
JP4173549B2 (ja) 2008-10-29
US20040209326A1 (en) 2004-10-21
DE69735207T2 (de) 2006-11-02
DE69735207D1 (de) 2006-04-13
ES2258280T3 (es) 2006-08-16
US6733758B1 (en) 2004-05-11
US7160990B2 (en) 2007-01-09
JP2001503609A (ja) 2001-03-21
WO1997048727A1 (en) 1997-12-24
SE9602496D0 (sv) 1996-06-20

Similar Documents

Publication Publication Date Title
DE69735207D1 (de) Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt
DE69534588D1 (de) Protocadherin-proteine und verwendungen davon
DK0397633T3 (da) Fibronectinbindende protein samt fremstilling deraf
ATE189475T1 (de) Wachstums-differenzierungsfaktor der tgf-b familie
AU2001294541A1 (en) Mammalian genes; related reagents and methods
ATE481480T1 (de) Methoden und zusammensetzungen zur herstellung von polypeptiden
PT737207E (pt) Inibidores de plasmina humana derivados de dominios kunitz
ATE345387T1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
BR9711795A (pt) Peptìdeos tendo propriedades antiproliferativas
TW200716746A (en) Methods for identifying a compound modulating the binding between polypeptides
MXPA02008239A (es) Gen humano de la esquizofrenia.
WO1995011975A3 (en) Retroviral superantigens, superantigen peptides, and methods of use
DE69535855D1 (de) Calciumbindende rekombinante antikörper gegen protein c
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
NO177570C (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
WO1994026891A3 (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
EP0990703A4 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
DE69534596D1 (de) Epil/plazentin
SE0003573D0 (sv) Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology
AU6839900A (en) Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein
EP1679372A4 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon
UA35624C2 (uk) МОЛЕКУЛА ДНК, ЩО КОДУЄ ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, ВЕКТОР, L-КЛІТИНА, ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, СПОСІБ ЙОГО ОТРИМАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, МОНОКЛОНАЛЬНЕ АНТИТІЛО

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties